Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic
24.07.2026 09:39 | The Guardian World
TGA says product information for some diabetes and weight loss drugs updated with warning of NAION disorderFollow our Australia news live blog for latest updatesGet our breaking news email, free app or daily news podcastAustralia’s medicines regulator has issued warnings for several type 2 diabetes and obesity-related treatments – including Ozempic and Mounjaro – over the potential to cause a “rare but severe” eye disorder that could lead to blindness.The Therapeutic Goods Administration’s (TGA) warning came after several GLP-1 RA medicines, marketed in Australia as Ozempic, Wegovy and Mounjaro among other products, have been linked to 36 cases of the condition. Continue reading...
🔗 Citește articolul complet pe The Guardian World🔎 Știri similare din The Guardian World
Times’s investigation adds more intrigue to infamous OJ S...
19.10.2026 02:35
Labor promises $30 weekly cap for Victorian public transp...
19.10.2026 02:20
Jacqui Lambie condemns One Nation cartoon mocking her str...
19.10.2026 02:01
🆕 Cele mai noi știri
Inside the shadowy world of anti-Putin sabotage from with...
19.10.2026 03:06 | BBC World
Jocurile gratuite de pe telefon îi pot costa scump pe păr...
19.10.2026 03:02 | Adev?rul
Cursă contra cronometru pentru noi sancțiuni împotriva Ru...
19.10.2026 02:48 | Mediafax
Times’s investigation adds more intrigue to infamous OJ S...
19.10.2026 02:35 | The Guardian World
EU tariffs aimed at China hitting Ukraine, steel boss says
19.10.2026 02:28 | BBC World
Labor promises $30 weekly cap for Victorian public transp...
19.10.2026 02:20 | The Guardian World